Methods and compositions including granulin/epithelin modules (GEMs) or combinations thereof suitable for treating neurodegenerative diseases. Also disclosed are methods of treatment of neurodegenerative diseases, such as methods of administering therapeutic recombinant GEM proteins or gene therapies for delivering recombinant GEM gene products.